[1]
2014. Clinical and economic aspects of the use of rituximab in non-Hodgkin’s lymphoma . Brazilian Journal of Pharmaceutical Sciences. 50, 3 (Sep. 2014), 445–455. DOI:https://doi.org/10.1590/S1984-82502014000300002.